1 | Programa provisional | 11/07/2016 | | CX/NFSDU 16/38/1 |
8 | Anteproyecto de directrices para los alimentos terapéuticos listos para el consumo
| 09/08/2016 | | CX/NFSDU 16/38/9 |
6 | Anteproyecto de definición del bioenriquecimiento | 15/08/2016 | | CX/NFSDU 16/38/7 |
7 | Anteproyecto de VRN-ENT para los ácidos grasos OMEGA 3 de cadena larga EPA y DHA | 06/09/2016 | | CX/NFSDU 16/38/8 |
5 | Revisión de la Norma para preparados complementarios (CODEX STAN 156-1987) | 05/10/2016 | | CX/NFSDU 16/38/6 |
4.1 | Proyecto NRV-R para la vitamina E | 21/10/2016 | | CX/NFSDU 16/38/4 |
8.1 | Anteproyecto de directrices para los alimentos terapéuticos listos
para el consumo (ATLC) | 19/10/2016 | | CX/NFSDU 16/38/9-Add.1 |
6.1 | Anteproyecto de definición del bioenriquecimiento | 17/10/2016 | | CX/NFSDU 16/38/7- Add.1 |
9 | Documento de debate sobre la declaración de propiedades “exento de ácidos grasos trans" | 15/11/2016 | | CX/NFSDU 16/38/10 |
4.2 | Anteproyecto de valores de referencia de nutrientes adicionales o revisados con fines de etiquetado de las Directrices del Codex sobre etiquetado nutricional (vitamina D y equivalentes alimentarios y factores de conversión para la vitamina E) en el trámite 4 (Observaciones en el trámite 3)
| 06/11/2016 | | CX/NFSDU 16/38/5 |
7.1 | Anteproyecto de VRN-ENT para los ácidos grasos omega 3 de cadena larga: EPA y DHA en el trámite 4 (Observaciones en el trámite 3)
| 06/11/2016 | | CX/NFSDU 16/38/8-Add.1 |
2 | Cuestiones remitidas al Comité por la Comisión del Codex Alimentarius y/u órganos auxiliares de la Comisión
| | | CX/NFSDU 16/38/2 |
10 | Armonización de las disposiciones sobre aditivos alimentarios de las normas para productos elaboradas por el CCNFSDU | 15/11/2016 | | CX/NFSDU 16/38/11 |
11 | Otros asuntos y trabajos futuros | 15/11/2016 | | CX/NFSDU 16/38/12 |
5.1 | Revisión de la Norma para preparados complementarios
(CODEX STAN 156-1987) - observaciones | 30/11/2016 | | CX/NFSDU 16/38/6-Add.1 |
3 | Cuestiones de interés planteadas por la FAO y la OMS | 02/12/2016 | | CX/NFSDU 16/38/3 |
100 | División de las Competencias entre la Unión Europea y sus Estados miembros según | 12/08/2016 | | CRD1 |
102 | Revisión de la Norma Para Preparados Complementarios (CODEX STAN 156-1987) - Informe del grupo de trabajo físico | 12/05/2016 | | CRD2 |
| Informe | 15/05/2017 | | |
0.1 | Information for delegates | 11/07/2016 | | |
6.2 | Proposed Draft Definition for Biofortification (comments at Step 3) | 17/11/2016 | | CX/NFSDU 16/38/7 Add.2 |
7.2 | Proposed draft NRV-NCD for EPA and DHA Long Chain Omega-3 fatty acids (comments at Step 3) | 17/11/2016 | | CX/NFSDU 16/38/8 Add.2 |
8.2 | Proposed Draft Guideline for Ready-to-Use Therapeutic Foods (comments at Step 3) | 17/11/2016 | | CX/NFSDU 16/38/9 Add.2 |
5.2 | Review of the Standard for Follow-up Formula (CODEX STAN 156-1987) (comments at Step 3) | 28/11/2016 | | CX/NFSDU16/38/6 Add.2 |
103 | Review of the standard for follow-up formula: comments of India, Indonesia, Kenya, Nigeria, African Union (Agenda 5) | 03/12/2016 | | CRD3 |
104 | Matters referred to the committee by the Codex Alimentarius Commission and/or other subsidiary bodies - Comments of European Union, Kenya, African Union, IDF and ISDI (Agenda 2) | 04/12/2016 | | CRD4 |
105 | Draft NRV-R for vitamin E - Comments of India, Malaysia, Mexico, Peru and the African Union (Agenda 4a) | 04/12/2016 | | CRD5 |
106 | Proposed draft additional or revised nutrient reference values for labelling (Vitamin D and the dietary equivalents and conversion factor for Vitamin E) - Comments of India, Indonesia, Malaysia, African Union, NHF (Agenda 4b) | 04/12/2016 | | CRD6 |
107 | Proposed draft definition for Biofortification - Comments of Ecuador, European Union. India, Nigeria, Peru, Thailand and the African Union (Agenda 6) | 04/12/2016 | | CRD7 |
108 | Proposed draft NRV-NCD for EPA and DHA long chain Omega-3 fatty acids - Comments of Ecuador, the European Union, Peru, Thailand and the African Union (Agenda 7) | 04/12/2016 | | CRD8 |
109 | Proposed Draft Guideline for Ready-to-use Therapeutic Foods - Comments of Ecuador, El Salvador, European Union, India, Kenya, Mexico, Nigeria, Thailand, African Union and FEDIOL (Agenda 8) | 04/12/2016 | | CRD9 |
110 | Discussion paper on claim for “free” of trans fatty acids - Comments of India, Indonesia, Kenya, Malaysia, Nigeria, United States of America, African Union, IDF and IFMA (Agenda 9) | 04/12/2016 | | CRD10 |
111 | Alignment of food additive provisions in standards developed by CCNFSDU - Comments of Nigeria, Thailand, African Union, IFMA and ISDI (Agenda 10) | 04/12/2016 | | CRD11 |
112 | Other business and future work - Comments of Mexico, Nigeria, Thailand, African Union and ISDI (Agenda 11) | 04/12/2016 | | CRD12 |
102.1 | Review of the Standard For Follow-Up Formula (CODEX STAN 156-1987) - Physical Working Group Report (Recommendation 11 – protein quality) | 05/12/2016 | | CRD13 |
113 | Comments of Benin | 05/12/2016 | | CRD14 |
114 | Comments of Chile, Mexico, ESPGHAN | 05/12/2016 | | CRD15 |
115 | Comments of Republic of Korea | 05/12/2016 | | CRD16 |
102.2 | PWG Side Session report: Modelling Macronutrient Levels | 05/12/2016 | | CRD17 |
116 | Methods of analysis for provisions in the standard for infant formula and formulas for special medical purposes intended for infants - PWG Side Session report: recommendations to the Committee | 06/12/2016 | | CRD18 |
117 | All files zip collection | | | |